We wish to report the characterization of CMRL-T, a novel hematopoietic cell line established at CEINGE-Advanced Biotechnologies Institute from the peripheral blood of a 13-year-old Italian girl affected by T-cell acute lymphoblastic leukemia (T-ALL) at relapse.
In October 1998, a 13-year-old female presented with liver, spleen and lymph nodes enlargement. Hematological parameters were as follows: white blood cell 400 000/ml (with 98% atypical lymphoid cells), hemoglobin 10.8 g/dl and platelets 17 000/ml. Flow cytometry disclosed a blast cell population positive for CD2, CD5, CD3, CD7, CD3cy, TdT and CD34, all these markers enabling the diagnosis of T-ALL. Molecular analysis excluded BCR/ABL rearrangements either at major breakpoint cluster region (M-bcr) or minor breakpoint cluster region (m-bcr). The patient was enrolled in an intermediate risk protocol (AIEOP 9502 ) that was successively changed with an intensive scheme (AIEOP 9503) owing to prednisone resistance. As the patient proved still resistant to the treatment, a salvage scheme (ifosfamide, carboplatin, etoposide) was adopted, following which partial remission was obtained. In March 1999, the patient was conditioned with busulfan and cyclophosphamide and transplanted with bone marrow from human leukocyte antigen (HLA)-matched brother. In April 1999, physical examination showed lymph nodes enlargement. Cytological investigations indicated a relapse characterized by the same leukemic population initially identified. After 4 months, the patient died for disease progression.
In April 1999, mononuclear cells from a peripheral blood sample were separated by density gradient centrifugation and seeded at 2 Â 10 6 /ml in T-25 culture flasks (Falcon, Becton Dickinson, San Jose, CA, USA) in Iscove's Modified Dulbecco's Medium (IMDM; Sigma Aldrich, St Louis, MO, USA) supplemented with 20% fetal bovine serum (Gibco BRL Life Technologies, Paisley, UK) and 2 mM L-glutamine (Sigma Aldrich). Neither growth factors nor exogenous feeder layers were used. The cells were incubated at 371C in a humidified 5% CO 2 atmosphere and fresh complete IMDM was added once a week, replacing half of the medium each time. In June 1999, small round cells forming clusters were visible and began to grow on a feeder layer of fibroblast-like cells. Since then, cells showed slow but stable proliferation. In November 2002, the cells exhibited a crisis period in which it was necessary to change tissue culture conditions. So, the cells were moved from T-25 tissue culture flasks to 24-well plate (Falcon, Becton Dickinson) and seeded at a cell concentration of 1 Â 10 6 /ml. In January 2003, the cells restarted to proliferate with regularity and in May 2003, they were judged as a continuous cell line and designated as CMRL-T. Then, the cells were cryopreserved until May 2005, when they were thawed, expanded in culture and characterized. The later passages showed a doubling time of about 72 h at a cell density of 0.5 Â 10 6 /ml (0.5-1.0 Â 10 6 /ml). Saturation density was approximately of 3 Â 10 6 /ml. CMRL-T phase contrast microscopy revealed a population composed by small, rounded to elongated cells growing in suspension as clusters and partly as single cells (Figure 1a ). After May-Grü nwald-Giemsa staining, cells showed medium to large size. Nuclei were rounded, moderately irregular, frequently indented, occasionally multilobated or bizarre. Chromatin distribution was heterogeneous, from condensed to fine. Nucleoli were lacking in the majority of cells. Occasionally, cells showed one nucleolus, very rarely two. Nuclei were surrounded by a subtle rim of slightly basophilic cytoplasm, with prominent vacuolization (Figure 1b) .
We followed international guidelines for mycoplasma testing, 1 performing polymerase chain reaction (PCR)-enzymelinked immunosorbent assay (Roche, Basel, Switzerland) analysis and culture identification under aerobic and anaerobic conditions (Oxoid, Basingstoke Hampshire, UK). We demonstrated that CMRL-T had no mycoplasma contamination. Tests were repeated monthly.
CMRL-T cell line was identified as unique by DNA fingerprint technique. CMRL-T DNA was compared to DNA obtained from patient's peripheral blood during relapse phase and cryopreserved in liquid nitrogen until use. The following nine highly polymorphic short tandem repeat loci were tested by three Letters to the Editor multiplex PCR reactions: D3S1358 (on chromosome 3), vWA (on chromosome 12p12), fibrinogen alpha-chain locus (FGA) (on chromosome 4q28), D8S1179 (on chromosome 8), D21S11 (on chromosome 21), D18S51 (on chromosome 18q21), D5S518 (on chromosome 5), D13S317 (on chromosome 13) and D7S820 (on chromosome 7). The multiplex PCR reaction conditions and primers were chosen according to previous description. 2 The size of amplified products was determined by a DNA capillary electrophoresis apparatus, ABI 310 Genetic Analyzer (PE Biosystems Italia, Monza, Italy), at a single-base definition. The fingerprint analysis of DNA showed that all nine loci were informative, that is, it was always possible to amplify two alleles with different length. A complete correspondence was detected between patient cells and the cell line, thus demonstrating the direct derivation of CMRL-T cell line from patient's leukemic cells.
Karyotype was assessed by culturing CMRL-T cells in the aforementioned conditions. CMRL-T cells were harvested following standard protocol, after exposure to 50 ml Colcemid (10 mg/ml) for 2 h. Chromosomes were G-banded with Wright stain and the karyotypes were described according to the ISCN (2005). 3 All cells showed 46,XX, der(3)t(3;17)(p14;p11),der(4) t(4;11)(p16;q13),del(6)(q21q23),del(11)(q23qter) [15] (Figure 2) . A near-triploid clone with identical structural rearrangements was also identified.
Cell viability was assessed routinely by analysis of flow cytometry light scatter properties, and cell count was performed by flow cytometry using a logical gate strategy based upon Trucount tubes (Becton Dickinson), according to the manufacturer's instruction.
The membrane expression of differentiation antigens was evaluated by flow cytometry by using a FACScalibur Flow cytometry results are shown in Table 1 . All data confirmed the T-ALL derivation, thanks to expression of CD2, CD5, CD3, CD7, TdT, CD4, TCRab and cytoplasmic CD3. CMRL-T cells were also positive for CD34, CD13, CD117, CD31, CD45R0, CD38, CD69 and CD95. CD1a was negative. One relevant feature of CMRL-T cell line was the simultaneous expression of antigens associated to an immature phenotype, such as CD34 and TdT, and of maturation-related specificities, such as TCRab, in the absence of CD1a. To date, 57 immature T-cell lines have been published and well characterized. 4 In particular, among these, only 10 T-cell lines display CD34 expression and only one, L-KAW, 4 shows the asynchronous phenotype CD34 þ /CD1aÀ/TCRab þ demonstrated for CMRL-T. In spite of this similarity, CMRL-T phenotype is unique owing to the expression of CD4, which is not displayed by L-KAW.
TCRb chain region variability was analyzed by flow cytometry by using TCR Vb Receptor Kit (Immunotech-Beckman Coulter) according to the manufacturer's instruction. The following 24 specificities were analyzed: Vb1, Vb2, Vb3, Vb4, Vb5.1, Vb5.2, Vb5.3, Vb7.1, Vb7.2, Vb8, Vb9, Vb11, Vb12, Vb13.1, Vb13.2, Vb13.6, Vb14, Vb16, Vb17, Vb18, Vb20, Vb21.3, Vb22, Vb23. Two out of 24 Vb regions were positive, that is, Vb3 and Vb12.
In order to confirm Vb repertoire results by reverse transcriptase (RT)-PCR, CMRL-T mRNA was obtained from 10 Â 10 6 cells using GenElute Mammalian Total RNA Miniprep Kit (Sigma) as described by the manufacturer. RT reaction was performed programming Thermal Cycler 480 as follow: 3 min at 851C followed by 1 h at 411C. PCR conditions and primers were chosen according to previous description. 5 PCR amplification of TCRb genes from the cDNA sample was performed in multiple tubes containing one of the Vb primer (CTG GAG TCC GCC AGC ACC A for Vb3 and CAC TCT GGA GTC CGC TAC C for Vb12 ), and the Cb primer (AGA TCT CTG CTT CTG ATG GCT C). RT-PCR analysis confirmed flow cytometry results showing that CMRL-T cells were able to express two different b chains (Vb3 and Vb12).
According to the data described, CMRL-T cell line may be defined as the clonal expansion of a 'dual-b chain' T-cell population. For many years it was considered that only one of the two b genes could be expressed in T cells, supporting the general rule of 'one cell, one receptor'. In 1995 it was demonstrated that allelic exclusion of one b gene is a rule but not a dogma, as it is possible to find within normal T cells a small cell subpopulation (1% of cells) expressing double TCRab, potentially able to recognize two different antigen specificities. 6 
Figure 2
G-banded karyotype. Rearranged chromosomes (3p, 4p, 6q, 11q, 17p) in the left side.
Letters to the Editor
The function of T-cell population equipped with double TCR is still not well understood owing to its paucity in tissues and to the limited lifespan of T cell cultured in vitro. Many authors are interested in the function of this cell subset both in physiological and pathological conditions. The molecular events involved in b-chain allelic exclusion are not well understood; it has been suggested the involvement of LCK gene. Transgenic mice that carry a dominant-negative mutant LCK gene present a significant reduction of allelic exclusion efficacy. 7 CMRL-T cell line may represent a useful tool to determine what kind of molecular and cellular mechanisms are involved in b-chain allelic exclusion and, on the other side, in double expression of TCR. To the best of our knowledge, only KT-1 cell line is able to express two different b chain mRNA molecules, as demonstrated by RT-PCR. Nevertheless, KT-1, derived from chronic myeloid leukemia in blast crisis, 8 does not represent a T-cell line as CMRL-T cells do. In conclusion, CMRL-T is a newly established cell line able to grow indefinitely in vitro maintaining its molecular and cellular features. It shows unique features not described for other T-cell line. On this basis, CMRL-T cell line can be a useful model to understand molecular and cellular mechanisms involved in Tcell ontogeny and TCRab expression regulation. This cell line will be made available to outside investigators upon request to the first author. 
